Trial Profile
A Double-blind, Randomized, Parallel, Placebo Controlled, Phase I/II Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH14618 Following Single Intradiscal Injection in Patients With Degenerative Disc Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs SB 01-Spine Biopharma (Primary)
- Indications Intervertebral disc degeneration
- Focus Adverse reactions
- Sponsors Yuhan
- 03 Nov 2017 Results presented at the North American Spine Society 30th annual meeting/ The Spine Journal.
- 27 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2014 New trial record